SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001387131-20-008175
Filing Date
2020-09-04
Accepted
2020-09-04 09:02:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS tnxp-424b5_090220.htm 424B5 6616
2 GRAPHIC tnxp424b5-01.jpg GRAPHIC 29819
  Complete submission text file 0001387131-20-008175.txt   48902
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237610 | Film No.: 201160705
SIC: 2834 Pharmaceutical Preparations